CTXR · CIK 0001506251 · operating
Citius Pharmaceuticals, Inc. (CTXR) is a pharmaceutical preparations company incorporated in NV, listed on the Nasdaq. With a market capitalization of $17 million, Citius Pharmaceuticals, Inc. is a micro-cap company. The stock currently trades at $0.72, down 2.34% today, with a 52-week range of $0.63–$2.48. The company trades at a forward P/E of 0.3x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-3.38 | $-3.38 | +43.4% | |
| 2024 | $-5.97 | $-5.97 | — | |
| 2023 | — | — | — | |
| 2022 | $-0.23 | $-0.23 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2013 | $0.00 | $0.00 | — | |
| 2012 | $0.00 | $0.00 | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-09-30 | 2025-12-23 | 0001213900-25-125333 | SEC ↗ |
| 2024-09-30 | 2024-12-27 | 0001213900-24-113149 | SEC ↗ |
| 2023-09-30 | 2023-12-29 | 0001213900-23-099889 | SEC ↗ |
| 2022-09-30 | 2022-12-22 | 0001213900-22-082217 | SEC ↗ |
| 2021-09-30 | 2021-12-15 | 0001213900-21-065464 | SEC ↗ |
| 2020-09-30 | 2020-12-16 | 0001213900-20-043004 | SEC ↗ |
| 2019-09-30 | 2019-12-16 | 0001213900-19-026259 | SEC ↗ |
| 2018-09-30 | 2018-12-11 | 0001213900-18-017214 | SEC ↗ |
| 2017-09-30 | 2017-12-13 | 0001213900-17-013191 | SEC ↗ |
| 2016-09-30 | 2016-12-23 | 0001477932-16-014315 | SEC ↗ |
| 2015-09-30 | 2015-12-14 | 0001477932-15-007617 | SEC ↗ |
| 2013-09-30 | 2014-02-06 | 0001185185-14-000261 | SEC ↗ |
| 2012-09-30 | 2013-01-15 | 0001185185-13-000090 | SEC ↗ |
| 2011-09-30 | 2012-01-13 | 0001185185-12-000067 | SEC ↗ |